Evaluation of ERCC1 and RRM1 as prognostic biomarkers in urothelial cancer (UC) treated with adjuvant platinum and gemcitabine chemotherapy.
Lauren Christine Harshman
No relevant relationships to disclose
Gerold Bepler
Consultant or Advisory Role - Lilly
Other Remuneration - Genzyme
David I. Quinn
No relevant relationships to disclose
Jesse McKenney
No relevant relationships to disclose
Debra Hawes
No relevant relationships to disclose
Noah Simon
No relevant relationships to disclose
Sandy Srinivas
No relevant relationships to disclose
Tanya B. Dorff
No relevant relationships to disclose